HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tangchun Wu Selected Research

Metalloids

8/2022Plasma metal concentrations and their interactions with genetic susceptibility on homocysteine levels.
12/2021Associations of plasma metal concentrations with the risks of all-cause and cardiovascular disease mortality in Chinese adults.
12/2021Associations of plasma metal concentrations with incident dyslipidemia: Prospective findings from the Dongfeng-Tongji cohort.
1/2020Multiple plasma metals, genetic risk and serum C-reactive protein: A metal-metal and gene-metal interaction study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tangchun Wu Research Topics

Disease

23Coronary Disease (Coronary Heart Disease)
01/2022 - 07/2004
23Lung Neoplasms (Lung Cancer)
01/2021 - 07/2006
19Neoplasms (Cancer)
01/2022 - 06/2007
15Cardiovascular Diseases (Cardiovascular Disease)
08/2022 - 01/2012
13Type 2 Diabetes Mellitus (MODY)
08/2022 - 07/2015
13Hypertension (High Blood Pressure)
01/2022 - 07/2004
7Genetic Predisposition to Disease (Genetic Predisposition)
08/2022 - 02/2016
7Stroke (Strokes)
11/2021 - 07/2004
7Carcinogenesis
01/2019 - 09/2006
5Acute Coronary Syndrome
11/2021 - 01/2011
5Overweight
10/2020 - 01/2016
5Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 06/2008
4Non-alcoholic Fatty Liver Disease
01/2022 - 01/2016
4Atherosclerosis
01/2021 - 01/2005
4Inflammation (Inflammations)
01/2020 - 03/2015
4Ischemic Stroke
01/2019 - 09/2004
3Genetic Risk Score
08/2022 - 08/2013
3Chronic Renal Insufficiency
12/2021 - 01/2020
3Obesity
10/2020 - 02/2016
3Heart Failure
01/2019 - 01/2013
3Hepatocellular Carcinoma (Hepatoma)
01/2018 - 04/2016
3Infections
01/2017 - 10/2014
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2012 - 01/2005
2Adenocarcinoma of Lung
01/2021 - 08/2010
2Asthma (Bronchial Asthma)
01/2019 - 02/2005
2Breast Neoplasms (Breast Cancer)
01/2018 - 01/2011
2Liver Neoplasms (Liver Cancer)
01/2018 - 01/2014
2Hyperlipidemias (Hyperlipidemia)
01/2018 - 01/2017
2Pathologic Processes
01/2017 - 03/2004
2Diabetes Mellitus
04/2016 - 10/2013
2Disease Susceptibility (Diathesis)
11/2015 - 01/2015
2Chronic Obstructive Pulmonary Disease (COPD)
05/2015 - 05/2015
2Pneumoconiosis
12/2014 - 01/2012
2Myocardial Ischemia (Ischemic Heart Diseases)
09/2014 - 01/2012
2Genomic Instability
05/2014 - 09/2009
2Myocardial Infarction
04/2014 - 10/2007
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2014 - 12/2010
2Xeroderma Pigmentosum (Kaposi's Disease)
06/2008 - 05/2007
2Atrial Fibrillation
01/2007 - 01/2004
2Noise-Induced Hearing Loss (Acoustic Trauma)
01/2006 - 01/2004
1Immune System Diseases (Immune Disorders)
03/2022

Drug/Important Bio-Agent (IBA)

14Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2006
11Glucose (Dextrose)FDA LinkGeneric
01/2022 - 10/2013
9Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2003
9MicroRNAs (MicroRNA)IBA
01/2022 - 04/2014
8Heat-Shock Proteins (Heat-Shock Protein)IBA
09/2010 - 01/2004
7MetalsIBA
08/2022 - 10/2017
7LipidsIBA
01/2022 - 01/2011
7ORALIT (ORS)IBA
12/2021 - 01/2013
7Biological ProductsIBA
01/2019 - 07/2006
6Uric Acid (Urate)IBA
01/2022 - 08/2013
6BilirubinIBA
01/2019 - 01/2016
6Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
06/2015 - 09/2006
5SeleniumIBA
08/2022 - 01/2019
5Coal (Coals)IBA
01/2021 - 08/2010
5CokeIBA
04/2017 - 05/2014
5AntibodiesIBA
01/2006 - 01/2004
4MetalloidsIBA
08/2022 - 01/2020
4ZincIBA
12/2021 - 01/2019
4CopperIBA
01/2021 - 01/2019
4SmokeIBA
01/2016 - 08/2010
4CholesterolIBA
01/2016 - 01/2006
4Silicon Dioxide (Silica)FDA LinkGeneric
12/2014 - 01/2012
4PlatinumIBA
01/2014 - 12/2010
4Chaperonin 60IBA
12/2008 - 01/2004
4HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
02/2005 - 01/2003
3ArsenicIBA
08/2022 - 12/2021
3Triglycerides (Triacylglycerol)IBA
01/2022 - 10/2014
3MolybdenumIBA
06/2020 - 01/2019
3IronIBA
01/2019 - 05/2014
3Blood Glucose (Blood Sugar)IBA
01/2018 - 01/2015
3DNA (Deoxyribonucleic Acid)IBA
07/2015 - 01/2013
3AntigensIBA
01/2014 - 01/2011
3EnzymesIBA
09/2010 - 06/2007
2Complement System Proteins (Complement)IBA
03/2022 - 12/2014
2Lactic Acid (Lactate)FDA LinkGeneric
01/2022 - 10/2020
2Antihypertensive Agents (Antihypertensives)IBA
01/2022 - 12/2017
2VanadiumIBA
12/2021 - 01/2019
2StrontiumIBA
12/2021 - 01/2019
2Urea (Carbamide)FDA LinkGeneric
01/2021 - 01/2017
2CreatinineIBA
01/2021 - 02/2020
2NitrogenIBA
01/2021 - 01/2017
2Indicators and Reagents (Reagents)IBA
10/2019 - 01/2005
2Alanine Transaminase (SGPT)IBA
03/2019 - 07/2015
2TitaniumIBA
01/2019 - 01/2019
2CytokinesIBA
01/2019 - 01/2017
2RubidiumIBA
01/2019 - 01/2019
2Fetal Proteins (Fetoprotein)IBA
01/2018 - 01/2014
2Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2017 - 07/2015
2CarcinogensIBA
11/2013 - 07/2006
2Selenium CompoundsIBA
05/2008 - 07/2007
1bisphenol AIBA
08/2022
1HomocysteineIBA
08/2022
1Peptides (Polypeptides)IBA
01/2022
1Amino AcidsFDA Link
01/2022
1glycylvalineIBA
01/2022
1VitaminsIBA
01/2022
1Alanine (L-Alanine)FDA Link
01/2022
1Glutamic Acid (Glutamate)FDA Link
01/2022

Therapy/Procedure

4Drug Therapy (Chemotherapy)
01/2014 - 12/2010